Shiseido Company, Limited
Stock Price Chart
2026/03/02 UpdatedPrice Trend
2026/03/02 UpdatedPrice & Trading Details
2026/03/02 UpdatedPRICE
TRADING
Analyst Recommendations 17 analysts
Updated 2026/03/01Earnings Calendar
Updated 2026/03/01Recent Earnings
| Date | EPS Est. | EPS Actual | Surprise |
|---|---|---|---|
| 2026/02/09 | ¥-12.79 | ¥8.27 | +164.7% |
| 2025/11/09 | ¥4.26 | ¥-133.97 | -3,244.8% |
| 2025/08/05 | ¥7.26 | ¥14.64 | +101.7% |
| 2025/05/11 | ¥8.01 | ¥9.23 | +15.2% |
Shareholder Composition
Updated 2026/03/01Top Mutual Funds / ETFs
Updated 2026/03/01Major Holders
Updated 2026/03/01| Fund Name | Ownership | Shares | Change |
|---|---|---|---|
|
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund
|
5.8M | -0.04% | |
|
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund
|
3.7M | +3.01% | |
|
iShares Trust-iShares Core MSCI EAFE ETF
|
2.7M | 0.00% | |
|
Fidelity Concord Street Trust-Fidelity International Index Fund
|
1.5M | +7.34% | |
|
iShares, Inc.-iShares MSCI Japan ETF
|
1.4M | -1.19% | |
|
iShares Trust-iShares MSCI EAFE ETF
|
1.4M | +1.06% |
| Institution | Ownership | Shares | Change |
|---|---|---|---|
|
Pacer Advisors, Inc.
|
3.5K | -4.39% |
Dividend History
Updated 2026/03/01| Year | Dividend | Change |
|---|---|---|
| 2025 | ¥40 | 0.0% |
| 2024 | ¥40 | -33.3% |
| 2023 | ¥60 | -40.0% |
| 2022 | ¥100 | +100.0% |
| 2021 | ¥50 | - |
Financial Performance
2026/03/01 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥1,009,966M | ¥1,067,355M | ¥973,038M | ¥990,586M |
| Gross Profit | ¥738,158M | ¥740,283M | ¥713,364M | ¥753,191M |
| Operating Income | ¥100,571M | ¥46,573M | ¥28,133M | ¥7,575M |
| Pretax Income | ¥102,940M | ¥54,055M | ¥38,611M | ¥5,137M |
| Net Income | ¥46,909M | ¥34,202M | ¥21,749M | -¥10,813M |
| EPS | ¥117.33 | ¥85.54 | ¥54.40 | -¥27.06 |
| Operating Margin | 9.96% | 4.36% | 2.89% | 0.76% |
| Balance Sheet | ||||
| Total Assets | ¥1,300,979M | ¥1,307,661M | ¥1,255,497M | ¥1,331,848M |
| Total Equity | ¥540,695M | ¥604,259M | ¥618,748M | ¥632,474M |
| Total Liabilities | ¥760,284M | ¥703,402M | ¥636,749M | ¥699,374M |
| Cash | ¥156,503M | ¥119,036M | ¥104,685M | ¥98,479M |
| Interest-bearing Debt | ¥305,837M | ¥297,188M | ¥280,981M | ¥363,160M |
| Equity Ratio | 41.56% | 46.21% | 49.28% | 47.49% |
| D/E Ratio | 0.57 | 0.49 | 0.45 | 0.57 |
| Cash Flow | ||||
| Operating CF | ¥134,249M | ¥46,735M | ¥89,026M | ¥48,403M |
| Investing CF | ¥66,733M | -¥41,308M | -¥35,536M | -¥83,738M |
| Financing CF | -¥190,575M | -¥52,418M | -¥75,642M | ¥23,357M |
| Free CF | ¥39,035M | -¥19,469M | ¥33,351M | -¥2,305M |
| Efficiency | ||||
| ROE | 8.68% | 5.66% | 3.52% | -1.71% |
| ROA | 3.61% | 2.62% | 1.73% | -0.81% |
Latest IR Information
-
Financial Summary for the Fiscal Year Ending December 2025 [IFRS] (Consolidated)
Consolidated net sales for the fiscal year ending December 2025 were JPY 969.92 billion (down 2.1% YoY), core operating income was JPY 44.52 billion (up 22.4% YoY), and net loss attributable to owners of the parent was JPY 40.68 billion....
Read more -
Notice Regarding the Differences Between Full-Year Consolidated Earnings Guidance and Actual Results for the Fiscal Year Ending December 2025
For the fiscal year ending December 2025, net sales amounted to ¥969,992 million (0.5% increase versus previous forecast), core operating income was ¥44,520 million (22.0% increase versus previous forecast), and net income attributable to owners of parent was a loss...
Read more -
Notice Regarding Recording of Equity Method Investment Valuation Loss in the 2025 December Term Individual Financial Summary
In the individual financial summary for the fiscal year ending December 2025, Shiseido recorded an equity method investment valuation loss of 180.3 billion yen as an extraordinary loss, with no impact on the consolidated financial results.
Read more -
Notice Regarding Receipt of Dividends from Consolidated Subsidiary
Received dividends of 50,358 million yen from consolidated subsidiary Shiseido Europe S.A. on September 1, 2025. No impact on consolidated financial results.
Read more -
Notice Regarding the Results of the Voluntary Retirement Program "Next Career Support Plan" at the Company and Some Domestic Subsidiaries
The number of participants in the voluntary retirement program "Next Career Support Plan" was 257, and expenses including special bonuses of approximately 3 billion yen are planned to be recorded as extraordinary items in the fourth quarter of the fiscal...
Read more
Latest News (5 items)
-
Average Analyst Rating: hold
Average Target Price: ¥2,776
Rating Score: 2.53 (Based on 17 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
Shiseido Company, Limited engages in the production and sale of cosmetics in Japan and internationally. It offers fragrances, skincare, and makeup products through retail channels. The company offers its products under BAUM, BENEFIQUE, Clé de Peau Beauté, Dr. Dennis Gross Skincare, Drunk Elephant, EFFECTIM, Gallinée, INOUI, IPSA, ISSEY MIYAKE PARFUMS, NARS, narciso rodriguez, Serge Lutens, SHISEIDO, THE GINZA, Tory Burch Beauty, Ulé, ZADIG&VOLTAIRE, ANESSA, AQUA LABEL, AUPRES, d program, ELIXIR, HAKU, INTEGRATE, MAJOLICA MAJORCA, MAQuillAGE, PRIOR, REVITAL, URARA, INRYU, The Collagen, and Perfect Cover brands. It also engages in the restaurant and food businesses; and operates beauty salons. In addition, the company operates and supports SABFA, a professional hair makeup training school. Further, it offers childcare facilities. The company sells its products through department, specialized cosmetic, drug, and general merchandise stores. Shiseido Company, Limited was founded in 1872 and is headquartered in Tokyo, Japan.
